Chong Boon Teo
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
- Health Informatics top 10%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 4
- Cancer Treatment and Pharmacology 3
- Gastroenterology top 10%
- Health top 10%
-
- Radiomics and Machine Learning in Medical Imaging 3
-
- Electrolyte and hormonal disorders 3
- Gastric Cancer Management and Outcomes 3
-
- Breast Cancer Treatment Studies 2
In The Last Decade
Chong Boon Teo
21 papers receiving 776 citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Infectious Diseases 361
- Health Informatics 20
- Oncology 234
- Gastroenterology 43
- Health 59
Countries citing papers authored by Chong Boon Teo
This map shows the geographic impact of Chong Boon Teo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Boon Teo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Boon Teo more than expected).
Fields of papers citing papers by Chong Boon Teo
This network shows the impact of papers produced by Chong Boon Teo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Boon Teo. The network helps show where Chong Boon Teo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chong Boon Teo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 12 | |
| 8 | 2022 | 9 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 67 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 16 | |
| 14 | 2022 | 18 | |
| 15 | 2022 | 4 | |
| 16 | Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysisbreakdown → | 2022 | 284 |
| 17 | 2022 | 21 | |
| 18 | 2021 | 112 | |
| 19 | 2021 | 25 | |
| 20 | 1987 | 39 |
About Chong Boon Teo
Chong Boon Teo is a scholar working on Sensory Systems, Gastroenterology and Oncology, having authored 26 papers that have together received 780 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), Cancer Treatment and Pharmacology (3 papers), COVID-19 Clinical Research Studies (3 papers), Electrolyte and hormonal disorders (3 papers), Gastric Cancer Management and Outcomes (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Infectious Diseases (361 citations), Health Informatics (20 citations) and Oncology (234 citations). Chong Boon Teo has collaborated with scholars based in Singapore, Australia and Germany. Frequent co-authors include Benjamin Kye Jyn Tan, Raghav Sundar, Yiong Huak Chan, Yu Yang Soon, Soo Chin Lee, Sen Hee Tay, Ainsley Ryan Yan Bin Lee, Mark Muthiah, Shi Yin Wong and Louis Yi Ann Chai.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.